10th PATIENT CENTRICITY & COLLABORATION WORLD CONGRESS 2027 EUROPE
Patient Partnership as the Engine of Innovation, Equity, and Trust
Millennium Hotel and Conference Centre Gloucester London
Day 1 - Thursday 25th February 2027
Hayley Chapman, Senior Program Director, The Synergist
PATIENT CENTRICITY, TRUST, & DIGITAL EMPOWERMENT
- How rising expectations from patients and regulators are reshaping engagement models across the entire development lifecycle
- The role of digital tools in strengthening transparency, improving communication, and reducing uncertainty
- Practical approaches for embedding patient voice into governance, decision‑making, and organisational culture
- What “patient‑first” leadership will require from biopharma organisations between now and 2030
Moderator:
Selena Freisens, MD, Head of Global Medical Affairs, Merz Therapeutics
Panellist:
Gunnar Philip, Head of Medical Affairs Europe Major Markets and Canada, CSL
- Approaches to ensuring fairness, explainability, and transparency in patient‑facing AI systems
- Strategies to improve accessibility and digital literacy for diverse patient populations
- Human‑centred design principles that reduce burden and create intuitive digital experiences
- Governance guardrails that support safe, responsible, and compliant AI deployment
- The new era of patient focused drug development
- Measuring the impact and value of patient engagement in R&D
- Accelerating systematic engagement in R&D
- Measuring uptake and impact
Michaela Dinboeck, Head Patient Engagement, Novartis
- Turning qualitative patient insights into strategic decisions that influence development and delivery
- Building cross‑functional alignment between R&D, medical affairs, commercial, and patient engagement teams
- Tools and frameworks for continuous feedback loops that capture evolving patient needs
- Metrics and maturity models that demonstrate organisational progress in patient centricity
Selena Freisens, MD, Head of Global Medical Affairs, Merz Therapeutics
- Personalised engagement journeys that adapt to patient needs and preferences
- Digital triage and symptom support tools that improve safety and responsiveness
- Scalable automation that enhances efficiency without compromising human connection
- Data‑driven optimisation that improves programme performance and patient outcomes
- AI‑supported feasibility modelling that identifies optimal sites and patient populations
- Hyper‑targeted outreach strategies that improve diversity and representation
- Predictive analytics that anticipate retention risks and guide proactive interventions
- Real‑time dashboards that support operational decision‑making and transparency
- Remote monitoring innovations that reduce burden and improve data quality
- Communication platforms that strengthen site–patient relationships and responsiveness
- Logistics solutions that streamline home‑health and decentralised trial operations
- Compliance safeguards that ensure data integrity and regulatory readiness
- Crafting authentic narratives that shift organisational mindsets and behaviours
- Co‑creating stories with patient partners to ensure accuracy and lived‑experience representation
- Embedding storytelling into training, leadership development, and internal culture
- Demonstrating how narrative power influences trial design and care pathways
Afternoon - Topic Focussed Stream Sessions
Patient Engagement, Behavioural Science & Experience Design
- Understanding patient motivations and barriers that influence long‑term adherence
- Designing behavioural nudges that support sustained engagement and healthier habits
- Personalised adherence pathways tailored to individual needs and disease contexts
- Measuring behavioural outcomes to demonstrate meaningful patient impact
- Automated personalisation that tailors content to patient preferences and behaviours
- Multilingual and accessible formats that broaden reach and inclusivity
- Engagement analytics that reveal patterns and guide continuous improvement
- Compliance‑ready workflows that ensure safe, consistent communication
- Simplifying complex medical information without losing scientific accuracy
- Designing digital content that is accessible, intuitive, and culturally relevant
- Supporting low‑literacy and multilingual populations through tailored communication
- Testing comprehension and usability to ensure messages truly resonate
- Communicating risk, uncertainty, and benefit in ways that empower patient decision‑making
- Improving clarity and consistency in clinical trial messaging across channels
- Using patient stories to build emotional connection and strengthen trust
- Avoiding misinformation pitfalls through proactive, evidence‑based communication
- Collaborating with grassroots organisations to reach underrepresented communities
- Building trust with “research‑naïve” populations through sustained local engagement
- Strengthening diversity in insights and trial participation through community‑led approaches
- Creating long‑term partnerships that extend beyond individual studies
- Collaborating with grassroots organisations to reach underrepresented communities
- Building trust with “research‑naïve” populations through sustained local engagement
- Strengthening diversity in insights and trial
participation through community‑led approaches - Creating long‑term partnerships that extend beyond individual studies
Clinical Research & Development, RWE & Digital Innovation
- Capturing early‑stage discovery insights that inform target selection and design
- Integrating patient perspectives throughout clinical development and protocol design
- Leveraging post‑launch feedback to refine support programmes and communication
- Building organisational capability for continuous patient involvement
- Predictive enrolment modelling that improves planning and resource allocation
- Automated site performance insights that highlight risks and opportunities
- Risk‑based monitoring tools that enhance quality and operational efficiency
- Operational intelligence dashboards that support real‑time decision‑making
- Emerging sensor‑based endpoints that capture continuous, real‑world patient data
- Remote monitoring approaches that enhance safety and early signal detection
- Integrating digital biomarkers into clinical workflows and decision‑making
- Navigating regulatory considerations for novel digital endpoints
- Capturing real‑world symptom burden to complement clinical trial data
- Linking RWE insights to clinical decision‑making and patient support strategies
- Improving post‑market understanding of tolerability and long‑term outcomes
- Enhancing safety signal detection through continuous real‑world monitoring
- Building risk‑proportionate oversight frameworks for AI‑enabled clinical tools
- Establishing transparency and explainability standards for algorithmic decision‑making
- Managing bias and ensuring fairness in clinical algorithms and predictive models
- Creating cross‑functional governance structures that support responsible innovation
- Aligning product goals with lived experience to ensure relevance and value
- Prioritising outcomes that matter most to patients and caregivers
- Improving development decision‑making through structured co‑design processes
- Case examples demonstrating how patient input reshapes TPP priorities
- Ethical digital transformation that prioritises patient autonomy and safety
- Global equity strategies that ensure inclusive access to research and care
- Patient‑driven innovation models that reshape development priorities
- New expectations for transparency, accountability, and partners
Moderator:
Panellists:
6:20 pm - 7:20 pm - NETWORKING DRINK RECEPTION
2026 Sponsors & Exhibitors
